Related references
Note: Only part of the references are listed.Design, synthesis and biological evaluation of novel indolinedione-coumarin hybrids as xanthine oxidase inhibitors
Harmandeep Kaur Gulati et al.
MEDICINAL CHEMISTRY RESEARCH (2020)
Xanthine oxidase inhibitors: patent landscape and clinical development (2015-2020)
Jatinder Vir Singh et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
被撤回的出版物: Alkannin inhibits proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of miR-92a (Retracted article. See vol. 146, 2022)
Baozhen Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Gout and hyperuricaemia in the USA: prevalence and trends
Gurkirpal Singh et al.
RHEUMATOLOGY (2019)
Natural compounds with xanthine oxidase inhibitory activity: A review
Arshad Mehmood et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway
Yuzhen Zhu et al.
PHARMACEUTICAL BIOLOGY (2019)
Unorthodox synthesis, biological activity and DFT studies of novel and multifunctionalized naphthoxocine derivatives
Mohamed Ahmed Abozeid et al.
RSC ADVANCES (2019)
Phytochemical composition and the cholinesterase and xanthine oxidase inhibitory properties of seed extracts from the Washingtonia filifera palm fruit
Sonia Floris et al.
RSC ADVANCES (2019)
Xanthine oxidase inhibitors from Archidendron clypearia (Jack.) IC Nielsen: Results from systematic screening of Vietnamese medicinal plants
Nguyen Thuy Duong et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2017)
Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism
Yahan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Antiviral activity of shikonin ester derivative PMM-034 against enterovirus 71 in vitro
Y. Zhang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)
Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis
Kiyonori Ito et al.
CEN CASE REPORTS (2014)
3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: A potential therapeutic agent for treatment of hyperuricemia and gout
Jian-Ming Lue et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Alkannins and Shikonins: A New Class of Wound Healing Agents
V. P. Papageorgiou et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Antioxidants from a Chinese medicinal herb - Lithospermum erythrorhizon
He Han et al.
FOOD CHEMISTRY (2008)
Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?
Jesse Dawson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
JF Baker et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Share Paper
